Literature DB >> 3108933

Some limitations of indices derived from signal detection theory: evaluation of an alternative index for measuring bias in memory tasks.

A Sahgal.   

Abstract

Mesh：

Substances：

Year:  1987        PMID： 3108933     DOI： 10.1007/bf00216022

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  6 in total

1.  The facilitation of discrimination performance by physostigmine sulphate.

Authors:  D M Warburton; K Brown
Journal:  Psychopharmacologia       Date:  1972

2.  Comparative effects of cholinergic drugs and lesions of nucleus basalis or fimbria-fornix on delayed matching in rats.

Authors:  S B Dunnett
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

3.  A comparison of different methods of assessing patterns of responding in discrete trial choice procedures.

Authors:  A Sahgal; G H Clincke
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

4.  Nonparametric indexes for sensitivity and bias: computing formulas.

Authors:  J B Grier
Journal:  Psychol Bull       Date:  1971-06       Impact factor: 17.737

5.  Effects of d-amphetamine and morphine on discrimination: signal detection analysis and assessment of response repetition in the performance deficits.

Authors:  W Koek; J L Slangen
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

Review 6.  A critique of the vasopressin-memory hypothesis.

Authors:  A Sahgal
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530
  6 in total
  34 in total

1.  Dissociation between the effects of benzodiazepine receptor agonists on behavioral vigilance and responsitivity.

Authors:  P Dudchenko; B Paul; M Sarter
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  GlyT-1 Inhibition Attenuates Attentional But Not Learning or Motivational Deficits of the Sp4 Hypomorphic Mouse Model Relevant to Psychiatric Disorders.

Authors:  Jared W Young; Mary E Kamenski; Kerin K Higa; Gregory A Light; Mark A Geyer; Xianjin Zhou
Journal:  Neuropsychopharmacology       Date:  2015-04-24       Impact factor: 7.853

3.  Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers.

Authors:  J Foulds; J Stapleton; J Swettenham; N Bell; K McSorley; M A Russell
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

4.  Nicotine or expectancies? Using the balanced-placebo design to test immediate outcomes of vaping.

Authors:  Amanda M Palmer; Thomas H Brandon
Journal:  Addict Behav       Date:  2019-04-26       Impact factor: 3.913

5.  Two types of bias in psychophysical detection and recognition procedures: nonparametric indices and effects of drugs.

Authors:  J L Katz
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  Sleep deprivation impairs performance in the 5-choice continuous performance test: similarities between humans and mice.

Authors:  Jordy van Enkhuizen; Dean Acheson; Victoria Risbrough; Sean Drummond; Mark A Geyer; Jared W Young
Journal:  Behav Brain Res       Date:  2013-12-12       Impact factor: 3.332

7.  Effects of nicotinic acetylcholine receptor ligands on behavioral vigilance in rats.

Authors:  J Turchi; L A Holley; M Sarter
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

8.  Caffeine expectancies influence the subjective and behavioral effects of caffeine.

Authors:  Paul T Harrell; Laura M Juliano
Journal:  Psychopharmacology (Berl)       Date:  2009-09-17       Impact factor: 4.530

9.  The alpha(2) antagonist idazoxan remediates certain attentional and executive dysfunction in patients with dementia of frontal type.

Authors:  J T Coull; B J Sahakian; J R Hodges
Journal:  Psychopharmacology (Berl)       Date:  1996-02       Impact factor: 4.530

10.  The 5-choice continuous performance test: evidence for a translational test of vigilance for mice.

Authors:  Jared W Young; Gregory A Light; Hugh M Marston; Richard Sharp; Mark A Geyer
Journal:  PLoS One       Date:  2009-01-19       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.